These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25688736)

  • 1. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.
    Chen ZY; Raghav K; Lieu CH; Jiang ZQ; Eng C; Vauthey JN; Chang GJ; Qiao W; Morris J; Hong D; Hoff P; Tran H; Menter DG; Heymach J; Overman M; Kopetz S
    Br J Cancer; 2015 Mar; 112(6):1088-97. PubMed ID: 25688736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
    Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y
    Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO.
    Dell'Aquila E; Cremolini C; Zeppola T; Lonardi S; Bergamo F; Masi G; Stellato M; Marmorino F; Schirripa M; Urbano F; Ronzoni M; Tomasello G; Zaniboni A; Racca P; Buonadonna A; Allegrini G; Fea E; Di Donato S; Chiara S; Tonini G; Tomcikova D; Boni L; Falcone A; Santini D
    Ann Oncol; 2018 Apr; 29(4):924-930. PubMed ID: 29324972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.
    Ock CY; Nam AR; Lee J; Bang JH; Lee KH; Han SW; Kim TY; Im SA; Kim TY; Bang YJ; Oh DY
    Gastric Cancer; 2017 Mar; 20(2):254-262. PubMed ID: 27147244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Dynamic Neutrophil-lymphocyte Ratio Changes in Patients With Colorectal Cancer.
    Ashizawa N; Furuya S; Katsutoshi S; Sudo M; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Inoue S; Kono H; Ichikawa D
    Anticancer Res; 2020 Apr; 40(4):2311-2317. PubMed ID: 32234931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer.
    Shibutani M; Maeda K; Nagahara H; Noda E; Ohtani H; Nishiguchi Y; Hirakawa K
    Anticancer Res; 2013 Aug; 33(8):3291-4. PubMed ID: 23898094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum and intratumoral cytokine profiles with tumor stage and neutrophil lymphocyte ratio in colorectal cancer.
    Kim YW; Kim SK; Kim CS; Kim IY; Cho MY; Kim NK
    Anticancer Res; 2014 Jul; 34(7):3481-7. PubMed ID: 24982357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival After TAS-102 Treatment of Patients With Metastatic Colorectal Cancer.
    Matsuda A; Yamada T; Matsumoto S; Sakurazawa N; Kawano Y; Shinozuka E; Sekiguchi K; Suzuki H; Yoshida H
    Anticancer Res; 2019 Aug; 39(8):4343-4350. PubMed ID: 31366528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer.
    He W; Yin C; Guo G; Jiang C; Wang F; Qiu H; Chen X; Rong R; Zhang B; Xia L
    Med Oncol; 2013 Mar; 30(1):439. PubMed ID: 23307251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer.
    Sunakawa Y; Yang D; Cao S; Zhang W; Moran M; Astrow SH; Hsiang J; Stephens C; Tsuji A; Takahashi T; Tanioka H; Negoro Y; Takagane A; Tani S; Yamaguchi T; Eto T; Fujii M; Ichikawa W; Lenz HJ
    Clin Colorectal Cancer; 2018 Dec; 17(4):e741-e749. PubMed ID: 30219280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis.
    Tang H; Li B; Zhang A; Lu W; Xiang C; Dong J
    PLoS One; 2016; 11(7):e0159447. PubMed ID: 27427969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis.
    Li MX; Liu XM; Zhang XF; Zhang JF; Wang WL; Zhu Y; Dong J; Cheng JW; Liu ZW; Ma L; Lv Y
    Int J Cancer; 2014 May; 134(10):2403-13. PubMed ID: 24122750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer.
    Kim JH; Lee JY; Kim HK; Lee JW; Jung SG; Jung K; Kim SE; Moon W; Park MI; Park SJ
    World J Gastroenterol; 2017 Jan; 23(3):505-515. PubMed ID: 28210087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?
    Chiang SF; Hung HY; Tang R; Changchien CR; Chen JS; You YT; Chiang JM; Lin JR
    Int J Colorectal Dis; 2012 Oct; 27(10):1347-57. PubMed ID: 22460305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer.
    Mercier J; Voutsadakis IA
    J Gastrointest Cancer; 2019 Sep; 50(3):493-506. PubMed ID: 29704170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy.
    Templeton AJ; Knox JJ; Lin X; Simantov R; Xie W; Lawrence N; Broom R; Fay AP; Rini B; Donskov F; Bjarnason GA; Smoragiewicz M; Kollmannsberger C; Kanesvaran R; Alimohamed N; Hermanns T; Wells JC; Amir E; Choueiri TK; Heng DY
    Eur Urol; 2016 Aug; 70(2):358-64. PubMed ID: 26924770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
    Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.